Stock NMTRQ 9 METERS BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases 9 Meters Biopharma, Inc.

Equities

NMTRQ

US6544052086

Market Closed - OTC Markets
Other stock markets
 09:30:05 2024-05-17 am EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for 9 Meters Biopharma, Inc. 0.00% 0.00%
Mar. 25 North American Morning Briefing : Tech in Focus on -2- DJ
2023 Bidding Procedure Approved for 9 Meters Biopharma, Inc. CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Celiac Disease Pipeline, Clinical Trials, FDA Approvals, and Emerging Drugs 2023 (Updated)
AQ
9 METERS BIOPHARMA, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Other Events (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Financial Statements and Exhibits (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
9 METERS BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Other Events (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
9 Meters Biopharma Announces Phase 3 Study of Vurolenatide in Short Bowel Syndrome
AQ
9 METERS BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
9 METERS BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
9 METERS BIOPHARMA, INC. : Other Events (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Other Events (form 8-K)
AQ
9 METERS BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NMTRQ Stock
  4. News 9 Meters Biopharma, Inc.
  5. Press Releases